Advanced Therapeutics · 2023 · 21 citations · 107 references
Life SciencesBiotechnologyPharmaceuticsDrug DeliveryNanotechnologyVirologyNanocarriers For TherapeuticsNanomedicineNanoparticle Delivery SystemsNanoparticle DesignNanoparticle FormulationsViral StructureDrug Delivery NanocarriersNanocarriersNanoparticle Delivery VectorsNanoparticlesSynthetic Gene CarriersVirally Derived Delivery Vectors
Abstract The rapid advancement of nanotechnology in recent years has opened new avenues of investigation for biomedical sciences. Viral nanoparticles (VNPs) are formulated from plant viruses, mammalian viruses, or bacteriophages. Based on their structure, viruses, and synthetic carriers have been utilized to design bio‐inspired nanocarriers, which serve as building blocks for innovative therapeutic applications. Scientists can chemically or genetically engineer VNPs to encompass various properties, such as enhancing their functionalization with therapeutic molecules and imaging reagents, enabling targeted delivery to specific ligands. The implementation of these novel nanocarrier platforms can revolutionize treatments for cancer, infectious diseases, and chronic illnesses. The primary goal of drug delivery systems is to localize cargo to the specific target site, increasing therapeutic benefits and minimizing off‐target effects. This review critically evaluates the major virus species used as nanocarriers, their applications in therapeutics, and their advantages and disadvantages.
107
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
Ana Rakita, Nenad Nikolić, Michael Mildner et al. · Scientific Reports · 2020 · 8.3K citations · Full text
Encyclopedia of biological chemistry
Choice Reviews Online · 2013 · 560 citations
In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
Patrick H. Lizotte, Amy M. Wen, Mee Rie Sheen et al. · Nature Nanotechnology · 2015 · 484 citations
Medicine, Immunology, Oncology +16
Cell-Specific Delivery of Diverse Cargos by Bacteriophage MS2 Virus-like Particles
Carlee E. Ashley, Eric C. Carnes, Genevieve K Phillips et al. · ACS Nano · 2011 · 355 citations · Full text
Pharmacy, Oncology, Pharmaceutics +17